Type 2 Diabetes

Impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) are categorized as stages in the natural history of disordered carbohydrate metabolism. They occur in all individuals as they progress from normal to diabetes, but since the transition through these states is rapid in type 1 diabetes, they are rarely identified in such individuals. Therefore, nearly all of the literature dealing with IGT and IFG is concerned with issues relating to type 2 diabetes, such as risk of developing type 2 diabetes and CVD.

Some think you can’t be too rich or too thin. A stylish female, type 2 diabetes, 46 years of age came into the office (a weight loss clinic) for a follow up. Everyone was telling her how great she looked. She said she was feeling great and excited because she could fit into clothes she couldn’t fit in the past few years. She lost 9 pounds in three months. She had not been self monitoring her glucose. She was thrilled, but her doctor wasn’t so thrilled, at least not yet. He was concerned her glucose was elevated.

Reasons may include poor metabolic control and extreme obesity.

Type 1 diabetes in children and youth is typically characterized by weight loss, polyuria, polydipsia, blurring of vision, very high plasma glucose concentrations, and ketonuria.

In this week's Homerun Slides, the action and safety of the type 2 medication, bromocriptine.

Study shows high carotenoid serum concentration may prevent development of type 2.

Study of 40-year trend focused on three ethnic groups prone to dental complications.

Patients who responded to medication had greater improvement in cardiometabolic risk factors.

Quality of life in obese patients with type 2 diabetes improved.

National cohort study examined events in Medicare beneficiaries.